In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy. Combining gene therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback